D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Booking.com
BKNG
|
+$634M |
| 2 |
Charles Schwab
SCHW
|
+$431M |
| 3 |
Walmart
WMT
|
+$421M |
| 4 |
Visa
V
|
+$400M |
| 5 |
Johnson & Johnson
JNJ
|
+$322M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$546M |
| 2 |
Salesforce
CRM
|
+$449M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$392M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$364M |
| 5 |
GE Aerospace
GE
|
+$345M |
Sector Composition
| 1 | Technology | 21.77% |
| 2 | Consumer Discretionary | 13.79% |
| 3 | Healthcare | 12.86% |
| 4 | Financials | 11.91% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
2626
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $231K | ﹤0.01% |
2,540
-25,342
| -91% | -$2.3M |
|
2627
Lennar Class B
LEN.B
$34B
| $229K | ﹤0.01% |
+2,702
| New | +$229K |
|
2628
Rexford Industrial Realty
REXR
$10.3B
| $227K | ﹤0.01% |
+3,812
| New | +$227K |
|
2629
Utah Medical Products
UTMD
$198M
| $226K | ﹤0.01% |
2,388
+300
| +14% | +$28.4K |
|
2630
Columbia Banking Systems
COLB
$7.83B
| $226K | ﹤0.01% |
10,550
-75,726
| -88% | -$1.62M |
|
2631
CVRx
CVRX
$209M
| $226K | ﹤0.01% |
24,202
+11,771
| +95% | +$110K |
|
2632
Senseonics Holdings
SENS
$377M
| $225K | ﹤0.01% |
317,574
-194,246
| -38% | -$138K |
|
2633
Northfield Bancorp
NFBK
$493M
| $225K | ﹤0.01% |
19,113
-26,522
| -58% | -$312K |
|
2634
H.B. Fuller
FUL
$3.37B
| $223K | ﹤0.01% |
+3,263
| New | +$223K |
|
2635
Red Violet
RDVT
$672M
| $223K | ﹤0.01% |
12,678
+186
| +1% | +$3.27K |
|
|
RERE
2636
ATRenew
RERE
$970M
| $222K | ﹤0.01% |
72,885
+16,168
| +29% | +$49.3K |
|
2637
Stem
STEM
$120M
| $221K | ﹤0.01% |
1,952
-420
| -18% | -$47.6K |
|
2638
Tarsus Pharmaceuticals
TARS
$2.06B
| $221K | ﹤0.01% |
+17,567
| New | +$221K |
|
2639
Credo Technology Group
CRDO
$27.9B
| $219K | ﹤0.01% |
+23,297
| New | +$219K |
|
2640
MarineMax
HZO
$565M
| $219K | ﹤0.01% |
7,619
-70,297
| -90% | -$2.02M |
|
2641
Atomera
ATOM
$107M
| $218K | ﹤0.01% |
34,255
-1,441
| -4% | -$9.18K |
|
2642
GCM Grosvenor Inc. Warrant
GCMGW
$31.1M
| $216K | ﹤0.01% |
383,617
+107,606
| +39% | +$60.7K |
|
2643
Sabra Healthcare REIT
SBRA
$4.59B
| $216K | ﹤0.01% |
+18,800
| New | +$216K |
|
|
GMS
2644
DELISTED
GMS Inc
GMS
| $216K | ﹤0.01% |
3,724
-44,333
| -92% | -$2.57M |
|
2645
Xeris Biopharma Holdings
XERS
$1.21B
| $215K | ﹤0.01% |
132,179
-30,200
| -19% | -$49.2K |
|
2646
The RMR Group
RMR
$288M
| $215K | ﹤0.01% |
+8,197
| New | +$215K |
|
2647
Gulfport Energy Corp
GPOR
$3.06B
| $215K | ﹤0.01% |
2,687
-32,977
| -92% | -$2.64M |
|
2648
Kimball Electronics
KE
$738M
| $214K | ﹤0.01% |
+8,899
| New | +$214K |
|
2649
Microvast
MVST
$1.05B
| $214K | ﹤0.01% |
+172,885
| New | +$214K |
|
2650
Vishay Intertechnology
VSH
$2.07B
| $214K | ﹤0.01% |
9,471
-5,544
| -37% | -$125K |
|